BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 31581815)

  • 1. Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trial.
    Ji L; McShane LM; Krailo M; Sposto R
    Clin Trials; 2019 Dec; 16(6):599-609. PubMed ID: 31581815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive adjustment of the randomization ratio using historical control data.
    Hobbs BP; Carlin BP; Sargent DJ
    Clin Trials; 2013; 10(3):430-40. PubMed ID: 23690095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the design and the analysis of stratified biomarker trials in the presence of measurement error.
    Halabi S; Lin CY; Liu A
    Stat Med; 2021 May; 40(12):2783-2799. PubMed ID: 33724513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using audit information to adjust parameter estimates for data errors in clinical trials.
    Shepherd BE; Shaw PA; Dodd LE
    Clin Trials; 2012 Dec; 9(6):721-9. PubMed ID: 22848072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian adaptive design for targeted therapy development in lung cancer--a step toward personalized medicine.
    Zhou X; Liu S; Kim ES; Herbst RS; Lee JJ
    Clin Trials; 2008; 5(3):181-93. PubMed ID: 18559407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-stage response adaptive randomization designs for multi-arm trials with binary outcome.
    Lu X; Shan G
    J Biopharm Stat; 2024 Jul; 34(4):526-538. PubMed ID: 37452825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A group sequential, response-adaptive design for randomized clinical trials.
    Karrison TG; Huo D; Chappell R
    Control Clin Trials; 2003 Oct; 24(5):506-22. PubMed ID: 14500050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-randomization tests in clinical trials.
    Proschan MA; Dodd LE
    Stat Med; 2019 May; 38(12):2292-2302. PubMed ID: 30672002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urn models for response-adaptive randomized designs: a simulation study based on a non-adaptive randomized trial.
    Ghiglietti A; Scarale MG; Miceli R; Ieva F; Mariani L; Gavazzi C; Paganoni AM; Edefonti V
    J Biopharm Stat; 2018; 28(6):1203-1215. PubMed ID: 29565749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simulation study of outcome adaptive randomization in multi-arm clinical trials.
    Wathen JK; Thall PF
    Clin Trials; 2017 Oct; 14(5):432-440. PubMed ID: 28982263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim analysis of binary outcome data in clinical trials: a comparison of five estimators.
    Lu QS; Chow SC; Tse SK
    J Biopharm Stat; 2019; 29(2):400-410. PubMed ID: 30599798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of Bayesian hierarchical models for adaptive randomization in biomarker-driven phase II studies.
    Barry WT; Perou CM; Marcom PK; Carey LA; Ibrahim JG
    J Biopharm Stat; 2015; 25(1):66-88. PubMed ID: 24836519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved adaptive randomization strategies for a seamless Phase I/II dose-finding design.
    Yan D; Wages NA; Dressler EV
    J Biopharm Stat; 2019; 29(2):333-347. PubMed ID: 30451068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simulation study for comparing testing statistics in response-adaptive randomization.
    Gu X; Lee JJ
    BMC Med Res Methodol; 2010 Jun; 10():48. PubMed ID: 20525382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doubly robust inference for targeted minimum loss-based estimation in randomized trials with missing outcome data.
    Díaz I; van der Laan MJ
    Stat Med; 2017 Oct; 36(24):3807-3819. PubMed ID: 28744883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weighted re-randomization tests for minimization with unbalanced allocation.
    Han B; Yu M; McEntegart D
    Pharm Stat; 2013; 12(4):243-53. PubMed ID: 23760923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials.
    Thall P; Fox P; Wathen J
    Ann Oncol; 2015 Aug; 26(8):1621-8. PubMed ID: 25979922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive biased urn randomization in small strata when blinding is impossible.
    Schouten HJ
    Biometrics; 1995 Dec; 51(4):1529-35. PubMed ID: 8589238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methods for control allocation in multiple arm studies using response adaptive randomization.
    Viele K; Broglio K; McGlothlin A; Saville BR
    Clin Trials; 2020 Feb; 17(1):52-60. PubMed ID: 31630567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.